drugset / Trial / NCT05006898
Compound to Control Presbyopia Symptoms
RandomizedParallel-groupDouble-blindTreatment
Summary
Low dose compose to control presbyopia symptoms
Timeline
- Start
- 2020-06-01
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | — | Other |
| Subject | Oxymetazoline | Other / unclassified | — | Other |
| Subject | Pilocarpine | Unknown | — | Other |